Drug Profile
Research programme: S-adenosylhomocysteine hydrolase inhibitors - Merck & Co
Alternative Names: L-002259713Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Purine nucleosides; Small molecules
- Mechanism of Action Adenosylhomocysteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA (PO)